EP1778723
IL-1 mótlyfssamsetningar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.8.2005EP published:
14.11.2012EP application number:
05789252.3
EP translation filed:
14.1.2013Grant published:
15.2.2013EPO information:
European Patent Register
Max expiry date:
16.8.2025Expiry date:
16.8.2022
Title:
IL-1 ANTAGONIST FORMULATIONS
Timeline
Today
17.8.2005EP application
14.11.2012EP Publication
14.1.2013Translation submitted
15.2.2013Registration published
16.8.2022Expires
Owner
Name:
REGENERON PHARMACEUTICALS, INC.Address:
777 Old Saw Mill River Road, 10591, Tarrytown, NY, US
Inventor
Name:
DIX, DanielAddress:
La Grangeville, NY, US
Name:
BOWERS, KatherineAddress:
Watertown, CT, US
Name:
CHIMANLALL, GoolcharranAddress:
Hopewell Junction, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
602137 PDate:
17.8.2004Country:
US
Classification
Categories:
A61K 39/17, A61K 9/08
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 1.8.2013
Expires: 16.8.2014
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 31.7.2014
Expires: 16.8.2015
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 4.8.2015
Expires: 16.8.2016
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 12
Paid: 20.7.2016
Expires: 16.8.2017
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 13
Paid: 24.7.2017
Expires: 16.8.2018
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 14
Paid: 19.7.2018
Expires: 16.8.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 15
Paid: 23.7.2019
Expires: 16.8.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 16
Paid: 21.7.2020
Expires: 16.8.2021
Payer: Patice ehf.
Number: 17
Paid: 20.7.2021
Expires: 16.8.2022
Payer: Patice ehf.